Lv11
88 积分 2022-04-11 加入
Disease stability in COPD following GOLD 2026-aligned initial therapy: a retrospective real-world study
1小时前
已完结
Can Patients With COPD Achieve and Maintain Disease Stability With Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Dual Therapy Budesonide/Formoterol: A FULFIL Post Hoc Analysis
1个月前
已关闭
Risk validation of a new quantitative score for clinical control of chronic obstructive pulmonary disease: The RADAR score
1个月前
已完结
FEF25-75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study
1个月前
已完结
Assessment tools for chronic obstructive pulmonary disease: do newer metrics allow for disease modification?
1个月前
已完结
Clinical Outcomes in Patients With COPD With Disease Stability
1个月前
已完结
From disease improvement to disease stability in patients with COPD: IMPACT post hoc analysis
1个月前
已关闭
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
1个月前
已完结
Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT® trial
1个月前
已完结
American translation, modification, and validation of the St. George's Respiratory Questionnaire
1个月前
已完结
皖公网安备34019202002308
